High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder.
about
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogeneticsMitochondrial dysfunction in bipolar disorder.Biological predictors of lithium response in bipolar disorder.Neurobiological findings in bipolar II disorder compared with findings in bipolar I disorder.Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.Distinctions between bipolar and unipolar depression.Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder.Post-receptor signaling pathways in the pathophysiology and treatment of mood disorders.Neuroplasticity and cellular resilience in mood disorders.Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment.Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder.The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression.The somatic common deletion in mitochondrial DNA is decreased in schizophreniaEndophenotypes in bipolar disorder.Regulation of ER stress proteins by valproate: therapeutic implications.Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience.Effects of dextroamphetamine, lithium chloride, sodium valproate and carbamazepine on intraplatelet Ca2+ levels.Translational potential of olfactory mucosa for the study of neuropsychiatric illness.Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.CACNA1C (Cav1.2) in the pathophysiology of psychiatric diseaseDefects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.Purinergic signaling and energy homeostasis in psychiatric disordersBipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses.Effect of dopamine on intracellular sodium: a common pathway for pharmacological mechanism of action in bipolar illness.Neurobiological trait abnormalities in bipolar disorder.Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.L-type calcium channels and psychiatric disorders: A brief review.The platelet window: examining receptor regulated second messenger processes in psychosis and depression.Effect of ionic stress on apoptosis and the expression of TRPM2 in human olfactory neuroepithelial-derived progenitors.Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder.Intellectual disability and cognitive ability in Darier disease: Swedish nation-wide study.Decreased levels of canonical transient receptor potential channel 3 protein in the rat cerebral cortex after chronic treatment with lithium or valproate.Perisomatic changes in h-channels regulate depressive behaviors following chronic unpredictable stress.Bcl-2 SNP rs956572 associates with disrupted intracellular calcium homeostasis in bipolar I disorder.Exclusion of the Darier's disease gene, ATP2A2, as a common susceptibility gene for bipolar disorder.Effect of mood stabilizers on gene expression in lymphoblastoid cells.TRPC Channels and Mental Disorders.A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.Effect of oxidative stress on TRPM2 and TRPC3 channels in B lymphoblast cells in bipolar disorder.
P2860
Q28081249-BDDE2DF6-D62D-4492-8055-4138FBF8F15EQ30640247-3054CBAF-9074-44A7-B6A1-3B46F357996EQ30794691-6448D41C-B80B-46DE-AF24-B44745B44A77Q30981655-3D596BDD-ADBF-492B-9C05-2E79B8863049Q33753311-96AE484D-B892-4CBF-917F-FCCB7F904064Q33773602-E523886D-BFF6-43EA-90C6-B4C8A921FFCFQ34099009-FF7A26D7-C8F4-4E7B-8FC7-0C8AA2A9150BQ34108573-A47B26CD-E705-4C97-9F4C-F9BFBD9B88F5Q34111006-D42E7E01-E3F6-4D4E-992D-3538A54521A4Q34186921-FE6547F9-D5E4-483B-BF1E-2EBC45C36F88Q34463272-F3985D79-39D9-4BA6-8D40-7F93494C1550Q34582990-00AFBC33-0BEA-4BF3-BF75-BFE5B91999E5Q34613536-29A05175-E4C8-46F7-BE92-D860D0FAB670Q34626051-0CCEB095-EA6F-4C6C-8A47-947FAD7D1755Q34692778-B73FE943-27E5-48BF-91BB-E5C13C6B71E0Q34994209-17C7A963-747E-4E40-AFFE-70BFE0D8BB36Q35098811-840B9055-7500-4423-836F-DC851F080EC0Q35101563-74E0BEDE-0B77-4430-97AE-3A2C4E8E7F99Q35161376-CF70765B-97F0-48CD-9F7F-7F62B69FA56FQ36070614-E5114D56-9AE4-492E-A634-2AAF28FD2354Q36281961-B3BE87D3-5A73-4AEF-8B50-76E54EC0D879Q37054253-9810CE3E-BD19-4A91-834E-D94BAE9F1382Q37284060-C6F7C3A7-A80E-46CC-B2FB-D9E05063DF4EQ37390908-2E9D4E34-A980-466F-8C08-D60D6C00ACC2Q37461068-BAF406C4-A250-441E-81D0-60EB88C41747Q37489488-5BC188BF-B878-4CFD-879E-E5E61E3A9307Q37607009-C6AC0428-F180-4C94-BB88-4F0C894332D8Q37795701-555E1221-8340-42E0-8F7E-82A68B1D0106Q38777353-E4D8617D-33CA-48DA-AE0D-111244A02619Q39662571-552EFB1D-A4E6-4AB5-9ACD-3C16B8ADBE14Q40097556-748CFFC2-97F6-4311-8C04-774D30177928Q41372379-FE9BD885-0A15-4BBA-B6CE-4D4953279A1FQ41959298-0D562148-9557-495A-93B3-004DD8AC90BFQ42380122-53BCCBD8-A3B2-437E-9083-F02FE7F8D8FEQ42483967-E0F67959-B840-4E06-8500-847C58ABFA22Q42644751-AE64B769-F358-4517-BEF3-F000D589CA56Q43233341-037C57C6-89A6-41D5-949E-EA3C6D3EA153Q46351373-5B99F468-0A81-4A2D-8829-69EAD8FA485BQ46471654-1CF1D1C9-7EE8-4E49-91E7-179C7D4524E1Q46703875-5C0BDEB0-9CB1-4BA1-AAA2-E0D68BC171B8
P2860
High intracellular calcium concentrations in transformed lymphoblasts from subjects with bipolar I disorder.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
High intracellular calcium con ...... jects with bipolar I disorder.
@en
type
label
High intracellular calcium con ...... jects with bipolar I disorder.
@en
prefLabel
High intracellular calcium con ...... jects with bipolar I disorder.
@en
P2093
P356
P1476
High intracellular calcium con ...... jects with bipolar I disorder.
@en
P2093
Emamghoreishi M
Schlichter L
P304
P356
10.1176/AJP.154.7.976
P407
P577
1997-07-01T00:00:00Z